Most rhesus macaques infected with the CCR5-tropic SHIVAD8 generate cross-reactive antibodies that neutralize multiple HIV-1 strains

被引:62
作者
Shingai, Masashi [1 ]
Donau, Olivia K. [1 ]
Schmidt, Stephen D. [2 ]
Gautam, Rajeev [1 ]
Plishka, Ronald J. [1 ]
Buckler-White, Alicia [1 ]
Sadjadpour, Reza [1 ]
Lee, Wendy R. [1 ]
LaBranche, Celia C. [3 ]
Montefiori, David C. [3 ]
Mascola, John R. [2 ]
Nishimura, Yoshiaki [1 ]
Martin, Malcolm A. [1 ]
机构
[1] NIAID, Mol Microbiol Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[3] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA
基金
美国国家卫生研究院;
关键词
HUMAN-IMMUNODEFICIENCY-VIRUS; RAPID DEVELOPMENT; TYPE-1; INFECTION; CELLS; MONKEYS; VACCINE; ISOLATE; BROAD; SERA; PATHOGENICITY;
D O I
10.1073/pnas.1217443109
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The induction of broadly reacting neutralizing antibodies has been a major goal of HIV vaccine research. Characterization of a pathogenic CCR5 (R5)-tropic SIV/HIV chimeric virus (SHIV) molecular clone (SHIVAD8-EO) revealed that eight of eight infected animals developed cross-reactive neutralizing antibodies (NAbs) directed against an envelope glycoprotein derived from the heterologous HIV-1(DH12) strain. A panel of plasmas, collected from monkeys inoculated with either molecularly cloned or uncloned SHIVAD8 stocks, exhibited cross-neutralization against multiple tier 1 and tier 2 HIV-1 clade B isolates. One SHIVAD8-infected animal also developed NAbs against clades A and C HIV-1 strains. In this particular infected macaque, the cross-reacting anti-HIV-1 NAbs produced between weeks 7 and 13 were directed against a neutralization-sensitive virus strain, whereas neutralizing activities emerging at weeks 41-51 targeted more neutralization-resistant HIV-1 isolates. These results indicate that the SHIVAD8 macaque model represents a potentially valuable experimental system for investigating B-cell maturation and the induction of cross-reactive NAbs directed against multiple HIV-1 strains.
引用
收藏
页码:19769 / 19774
页数:6
相关论文
共 37 条
[1]   RAPID DEVELOPMENT OF ISOLATE-SPECIFIC NEUTRALIZING ANTIBODIES AFTER PRIMARY HIV-1 INFECTION AND CONSEQUENT EMERGENCE OF VIRUS VARIANTS WHICH RESIST NEUTRALIZATION BY AUTOLOGOUS SERA [J].
ALBERT, J ;
ABRAHAMSSON, B ;
NAGY, K ;
AURELIUS, E ;
GAINES, H ;
NYSTROM, G ;
FENYO, EM .
AIDS, 1990, 4 (02) :107-112
[2]   Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C [J].
Binley, James M. ;
Lybarger, Elizabeth A. ;
Crooks, Emma T. ;
Seaman, Michael S. ;
Gray, Elin ;
Davis, Katie L. ;
Decker, Julie M. ;
Wycuff, Diane ;
Harris, Linda ;
Hawkins, Natalie ;
Wood, Blake ;
Nathe, Cory ;
Richman, Douglas ;
Tomaras, Georgia D. ;
Bibollet-Ruche, Frederic ;
Robinson, James E. ;
Morris, Lynn ;
Shaw, George M. ;
Montefiori, David C. ;
Mascola, John R. .
JOURNAL OF VIROLOGY, 2008, 82 (23) :11651-11668
[3]   Autologous neutralizing humoral immunity and evolution of the viral envelope in the course of subtype B human immunodeficiency virus type 1 infection [J].
Bunnik, Evelien M. ;
Pisas, Linaida ;
van Nuenen, Ad C. ;
Schuitemaker, Hanneke .
JOURNAL OF VIROLOGY, 2008, 82 (16) :7932-7941
[4]  
Committee on Care and Use of Laboratory Animals, 1985, DHHS PUBL, V85-23
[5]   Breadth of Human Immunodeficiency Virus-Specific Neutralizing Activity in Sera: Clustering Analysis and Association with Clinical Variables [J].
Doria-Rose, Nicole A. ;
Klein, Rachel M. ;
Daniels, Marcus G. ;
O'Dell, Sijy ;
Nason, Martha ;
Lapedes, Alan ;
Bhattacharya, Tanmoy ;
Migueles, Stephen A. ;
Wyatt, Richard T. ;
Korber, Bette T. ;
Mascola, John R. ;
Connors, Mark .
JOURNAL OF VIROLOGY, 2010, 84 (03) :1631-1636
[6]   Frequency and Phenotype of Human Immunodeficiency Virus Envelope-Specific B Cells from Patients with Broadly Cross-Neutralizing Antibodies [J].
Doria-Rose, Nicole A. ;
Klein, Rachel M. ;
Manion, Maura M. ;
O'Dell, Sijy ;
Phogat, Adhuna ;
Chakrabarti, Bimal ;
Hallahan, Claire W. ;
Migueles, Stephen A. ;
Wrammert, Jens ;
Ahmed, Rafi ;
Nason, Martha ;
Wyatt, Richard T. ;
Mascola, John R. ;
Connors, Mark .
JOURNAL OF VIROLOGY, 2009, 83 (01) :188-199
[7]   Neutralization activity in a geographically diverse East London cohort of human immunodeficiency virus type 1-infected patients: clade C infection results in a stronger and broader humoral immune response than clade B infection [J].
Dreja, Hanna ;
O'Sullivan, Eithne ;
Pade, Corinna ;
Greene, Kelli M. ;
Gao, Hongmei ;
Aubin, Keith ;
Hand, James ;
Isaksen, Are ;
D'Souza, Carl ;
Leber, Werner ;
Montefiori, David ;
Seaman, Michael S. ;
Anderson, Jane ;
Orkin, Chloe ;
McKnight, Aine .
JOURNAL OF GENERAL VIROLOGY, 2010, 91 :2794-2803
[8]   Short- and long-term clinical outcomes in rhesus monkeys inoculated with a highly pathogenic chimeric simian/human immunodeficiency virus [J].
Endo, Y ;
Igarashi, T ;
Nishimura, Y ;
Buckler, C ;
Buckler-White, A ;
Plishka, R ;
Dimitrov, DS ;
Martin, MA .
JOURNAL OF VIROLOGY, 2000, 74 (15) :6935-6945
[9]   Longitudinal Analysis of Early HIV-1-Specific Neutralizing Activity in an Elite Neutralizer and in Five Patients Who Developed Cross-Reactive Neutralizing Activity [J].
Euler, Zelda ;
van den Kerkhof, Tom L. G. M. ;
van Gils, Marit J. ;
Burger, Judith A. ;
Edo-Matas, Diana ;
Pham Phung ;
Wrin, Terri ;
Schuitemaker, Hanneke .
JOURNAL OF VIROLOGY, 2012, 86 (04) :2045-2055
[10]   Pathogenicity and Mucosal Transmissibility of the R5-Tropic Simian/Human Immunodeficiency Virus SHIVAD8 in Rhesus Macaques: Implications for Use in Vaccine Studies [J].
Gautam, Rajeev ;
Nishimura, Yoshiaki ;
Lee, Wendy R. ;
Donau, Olivia ;
Buckler-White, Alicia ;
Shingai, Masashi ;
Sadjadpour, Reza ;
Schmidt, Stephen D. ;
LaBranche, Celia C. ;
Keele, Brandon F. ;
Montefiori, David ;
Mascola, John R. ;
Martin, Malcolm A. .
JOURNAL OF VIROLOGY, 2012, 86 (16) :8516-8526